Suppr超能文献

维持性血液透析高血压患者肾上腺髓质素水平升高

[Increased adrenomedullin levels in hypertensive patients on maintenance hemodialysis].

作者信息

Cases A, Esforzado N, Vera M, Lario S, López-Pedret J, Jiménez W, Rivera-Fillat F

机构信息

Servicio de Nefrología, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Universidad de Barcelona.

出版信息

Nefrologia. 2000 Sep-Oct;20(5):424-30.

Abstract

Hypertension is a frequent finding in uremic patients. The pathogenesis of this complication in uremia is complex and not fully elucidated. An imbalance between the vasoconstrictor and vasodilator systems may be involved in its pathogenesis. In this study we have evaluated the state of nitric oxide (NO) and adrenomedullin (ADM) in hemodialyzed patients, especially those with hypertension. We included a group of hypertensive hemodialyzed patients (n = 9) and a group of normotensive control patients (n = 10). We measured plasma renin activity, as well as plasma catecholamines, ADM, and nitrite/nitrate levels in basal conditions before starting the hemodialysis session. Plasma volume, as well as left ventricular ejection fraction were also measured. Hemodialysis patients showed plasma levels of nitrite/nitrates and ADM higher than the reference values in the normal population. We observed no differences in the plasma levels of nitrite/nitrates, but ADM levels were higher in hypertensive (278.2 +/- 15.5 pg/ml) patients than in normotensive patients (225 +/- 9.9 pg/ml) (p < 0.05). When considering all patients together, mean arterial pressure positively correlated with plasma ADM (r = 0.468, p < 0.05). Plasma volume and left ventricular ejection fraction were similar in the two groups of patients. In summary, plasma levels of nitrite/nitrates and ADM are increased in hemodialyzed patients, although only ADM levels were further increased in hypertensive patients. Our results do not suggest that a decreased production in the vasodilator factors evaluated is involved in the pathogenesis of hypertension in uremic patients.

摘要

高血压在尿毒症患者中很常见。尿毒症这种并发症的发病机制复杂,尚未完全阐明。血管收缩系统和血管舒张系统之间的失衡可能参与其发病机制。在本研究中,我们评估了血液透析患者,尤其是高血压患者体内一氧化氮(NO)和肾上腺髓质素(ADM)的状态。我们纳入了一组高血压血液透析患者(n = 9)和一组血压正常的对照患者(n = 10)。在开始血液透析治疗前的基础状态下,我们测量了血浆肾素活性以及血浆儿茶酚胺、ADM和亚硝酸盐/硝酸盐水平。还测量了血浆容量以及左心室射血分数。血液透析患者的血浆亚硝酸盐/硝酸盐和ADM水平高于正常人群的参考值。我们观察到亚硝酸盐/硝酸盐的血浆水平没有差异,但高血压患者(278.2 +/- 15.5 pg/ml)的ADM水平高于血压正常的患者(225 +/- 9.9 pg/ml)(p < 0.05)。当将所有患者综合考虑时,平均动脉压与血浆ADM呈正相关(r = 0.468,p < 0.05)。两组患者的血浆容量和左心室射血分数相似。总之,血液透析患者的血浆亚硝酸盐/硝酸盐和ADM水平升高,尽管只有高血压患者的ADM水平进一步升高。我们的结果并不表明所评估的血管舒张因子产生减少参与了尿毒症患者高血压的发病机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验